Search
Selected Clients & Industries Served

While appraisers rely on universal principals, each industry has unique characteristics which influence how these principals are applied. In the biopharmaceuticals and medical device industries, the regulatory process governs the timing and likelihood of new product introductions. In software, accounting standards for revenue recognition can foster an apparent disparity between bookings and sales. Rapidly growing companies in fields such as information security may be valued based on their expected results rather than their recent results. With its broad industry experience, Orchard understands which tools are appropriate for each appraisal assignment.

Biopharma
  • Aileron Therapeutics
  • Flexion Therapeutics
  • Enanta
  • Proteon
Software & Hosted Solutions
  • Axeda
  • Charles River Dev.
  • MetraTech
Networking, Storage & Security
  • Crossbeam
  • Imprivata
  • Q1 Labs (acquired)

Healthcare Applications
  • PatientKeeper
  • NaviNet
  • SleepMed
Medical Devices & Diagnostics
  • Intrinsic Therapeutics
  • LeMaitre Vascular
  • TEI Biosciences

Other
  • Affinnova
  • Best Doctors
  • Brainshark
  • Undertone Networks
From Our Blog

9/24/2013 2:40 PM
Valuing Common Stock in Anticipation of a Biotech IPO

My article “Valuing Common Stock in Anticipation of a Biotech IPO” appeared in the May 2012 issue of Business Valuation Update, published by... (more)